Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06497569 · ClinicalTrials.gov registry record · NA
Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
A NA study of GastroEsophageal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT06497569: Recruiting NA study of GastroEsophageal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT06497569 is a NA study of GastroEsophageal Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 80 participants, below the 494-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06497569, a NA study of GastroEsophageal Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.
Primary Outcome
The Study will be deemed feasible ≥ 50% of eligible patients are enrolled.
Conditions Studied
Interventions
- BEHAVIORAL Fitbit Data Collection
- BEHAVIORAL Survey
- BEHAVIORAL Dietitian Consultation
- BEHAVIORAL Referral to Dietitian
- BEHAVIORAL Social Determinants of Health Survey (SDOH)
Study Locations (2)
Florida
- Moffitt Cancer Center - Tampa
North Carolina
- UNC Lineberger Comprehensive Cancer Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-07-26 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06497569 shows while recruiting
NCT06497569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 494-participant average among 23 other GastroEsophageal Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with GastroEsophageal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Fitbit Data Collection is the first listed.
NCT06497569 reports a single indexed study location in Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06497569 about?
NCT06497569 is a clinical study titled "Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer". The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.
What is the current status of trial NCT06497569?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-07-26. Estimated completion is 2027-06.
What conditions does trial NCT06497569 study?
This clinical trial studies the following conditions: GastroEsophageal Cancer.
What interventions are being tested in trial NCT06497569?
The interventions under investigation include: Fitbit Data Collection (BEHAVIORAL), Survey (BEHAVIORAL), Dietitian Consultation (BEHAVIORAL), Referral to Dietitian (BEHAVIORAL), Social Determinants of Health Survey (SDOH) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06497569?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06497569 being conducted?
This trial has 2 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GastroEsophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06497569's enrollment target sits among peer trials
80 7th of 23 higher than 17 of 23 other GastroEsophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other GastroEsophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supportive Oncology Care At Home RCT
ACTIVE NOT RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
ACTIVE NOT RECRUITING · NA
-
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
RECRUITING · Phase 2
-
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
RECRUITING · Phase 2
-
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI